The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of nivolumab in patients with recurrent or metastatic carcinosarcomas.
 
Miso Kim
Honoraria - Astellas Pharma; Merck; Novartis; Yuhan
Consulting or Advisory Role - Astellas Pharma; Bayer; Bayer; Boryung; Bristol-Myers Squibb/Ono Pharmaceutical; Eisai; Ipsen; Janssen; Merck; MSD; Pfizer; Roche; Yuhan
 
Jung Yong Hong
No Relationships to Disclose
 
Min Hwan Kim
Stock and Other Ownership Interests - AIMA company
Honoraria - AstraZeneca; Boryung Pharmaceuticals; Boryung Pharmaceuticals; Celltrion; Celltrion; Daiichi Sankyo; Eisai; MSD
Consulting or Advisory Role - Boryung Pharmaceuticals; Daiichi Sankyo; Eisai
Research Funding - AstraZeneca; Boryung Pharmaceuticals; Celltrion; Daewoong Pharmaceutical
 
Minkyu Jung
Employment - Ensol Biosciences (I)
Stock and Other Ownership Interests - Ensol Biosciences; Ensol Biosciences (I)
Honoraria - Celltrion; Lilly
 
Gun Min Kim
No Relationships to Disclose
 
Kyoo Hyun Kim
No Relationships to Disclose
 
Kum-Hee Yun
No Relationships to Disclose
 
Su-Jin Shin
No Relationships to Disclose
 
Young Han Lee
No Relationships to Disclose
 
Jiwoo Park
No Relationships to Disclose
 
Jeeyun Lee
Consulting or Advisory Role - AstraZeneca; Guardant Health AMEA; Mirati Therapeutics; Oncologie; Trutino Biosciences
Research Funding - AstraZeneca; Merck Sharp & Dohme
 
Hyo Song Kim
No Relationships to Disclose